Literature DB >> 8738158

Analysis of interaction sites in homo- and heteromeric complexes containing Bcl-2 family members and the cellular prion protein.

C Kurschner1, J I Morgan.   

Abstract

The cellular prion protein (PrP) binds to the C-terminus of Bcl-2 but not Bax. Therefore, we examined whether the C-terminus of Bcl-2 was important for other homomeric and heteromeric protein-protein interactions. Using the yeast two hybrid system and co-immunoprecipitation, three sites of homomeric interactions were identified within Bcl-2. The carboxy terminal 37 amino acids selectively homodimerized. Two additional regions of Bcl-2 (residues 1-129 and 126-200) interacted with each other, but not themselves permitting both intra- and intermolecular association. In addition, we analyzed heteromeric interactions of Bcl-2 with PrP and two Bcl-2 related proteins, Bax and A1. The domain requirements for binding of those three proteins to Bcl-2 were different from one another. Bax binding required almost the entire Bcl-2 molecule, while A1 bound to the amino terminal region (residues 1-82). PrP associated with the carboxy terminus of Bcl-2 (amino acids 200-236). These data suggest configurational models for Bcl-2 containing complexes. First, Bcl-2 may exist as both heterodimers and heteromultimers. Second, molecules such as Bax and A1 may serve to cap chains of Bcl-2 homodimers by interacting with dimerization domains in the extramembrane region. PrP may disrupt chains of Bcl-2 molecules at the homomeric association site in the transmembrane region.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8738158     DOI: 10.1016/0169-328x(95)00323-k

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  19 in total

1.  Dynamic changes and surveillance function of prion protein expression in gastric cancer drug resistance.

Authors:  Ji-Heng Wang; Jing-Ping Du; Ying-Hai Zhang; Xiao-Jun Zhao; Ru-Ying Fan; Zhi-Hong Wang; Zi-Tao Wu; Ying Han
Journal:  World J Gastroenterol       Date:  2011-09-21       Impact factor: 5.742

2.  Recombinant prion protein does not possess SOD-1 activity.

Authors:  Samantha Jones; Mark Batchelor; Daljit Bhelt; Anthony R Clarke; John Collinge; Graham S Jackson
Journal:  Biochem J       Date:  2005-12-01       Impact factor: 3.857

3.  Association of Bcl-2 with misfolded prion protein is linked to the toxic potential of cytosolic PrP.

Authors:  Angelika S Rambold; Margit Miesbauer; Doron Rapaport; Till Bartke; Michael Baier; Konstanze F Winklhofer; Jörg Tatzelt
Journal:  Mol Biol Cell       Date:  2006-05-17       Impact factor: 4.138

4.  c-Maf interacts with c-Myb to regulate transcription of an early myeloid gene during differentiation.

Authors:  S P Hedge; A Kumar; C Kurschner; L H Shapiro
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

Review 5.  Potential roles for prions and protein-only inheritance in cancer.

Authors:  H Antony; A P Wiegmans; M Q Wei; Y O Chernoff; K K Khanna; A L Munn
Journal:  Cancer Metastasis Rev       Date:  2012-06       Impact factor: 9.264

6.  Cbln1 is essential for interaction-dependent secretion of Cbln3.

Authors:  Dashi Bao; Zhen Pang; Marc A Morgan; Jennifer Parris; Yongqi Rong; Leyi Li; James I Morgan
Journal:  Mol Cell Biol       Date:  2006-10-09       Impact factor: 4.272

7.  Neuronal interleukin-16 (NIL-16): a dual function PDZ domain protein.

Authors:  C Kurschner; M Yuzaki
Journal:  J Neurosci       Date:  1999-09-15       Impact factor: 6.167

8.  Absence of the cellular prion protein exacerbates and prolongs neuroinflammation in experimental autoimmune encephalomyelitis.

Authors:  Shigeki Tsutsui; Jennifer N Hahn; Trina A Johnson; Zenobia Ali; Frank R Jirik
Journal:  Am J Pathol       Date:  2008-10       Impact factor: 4.307

Review 9.  Immunotherapy in prion disease.

Authors:  Yvonne Roettger; Yansheng Du; Michael Bacher; Inga Zerr; Richard Dodel; Jan-Philipp Bach
Journal:  Nat Rev Neurol       Date:  2012-12-18       Impact factor: 42.937

10.  Cytosolic prion protein is the predominant anti-Bax prion protein form: exclusion of transmembrane and secreted prion protein forms in the anti-Bax function.

Authors:  David T S Lin; Julie Jodoin; Michaël Baril; Cynthia G Goodyer; Andréa C Leblanc
Journal:  Biochim Biophys Acta       Date:  2008-06-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.